Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Molecular Genetics of Myeloproliferative Neoplasms
Anna E. Marneth, Ann Mullally
Cold Spring Harbor Perspectives in Medicine (2019) Vol. 10, Iss. 2, pp. a034876-a034876
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

The JAK–STAT pathway: an emerging target for cardiovascular disease in rheumatoid arthritis and myeloproliferative neoplasms
Chiara Baldini, Francesca Romana Moriconi, Sara Galimberti, et al.
European Heart Journal (2021) Vol. 42, Iss. 42, pp. 4389-4400
Open Access | Times Cited: 110
Genomic profiling of a randomized trial of interferon-α vs hydroxyurea in MPN reveals mutation-specific responses
Trine Alma Knudsen, Vibe Skov, Kristen E. Stevenson, et al.
Blood Advances (2021) Vol. 6, Iss. 7, pp. 2107-2119
Open Access | Times Cited: 43
Next Generation Sequencing in MPNs. Lessons from the Past and Prospects for Use as Predictors of Prognosis and Treatment Responses
Vibe Skov
Cancers (2020) Vol. 12, Iss. 8, pp. 2194-2194
Open Access | Times Cited: 35
Molecular Pathogenesis of Myeloproliferative Neoplasms
Benjamin Rolles, Ann Mullally
Current Hematologic Malignancy Reports (2022) Vol. 17, Iss. 6, pp. 319-329
Closed Access | Times Cited: 20
Exploring the Molecular Aspects of Myeloproliferative Neoplasms Associated with Unusual Site Vein Thrombosis: Review of the Literature and Latest Insights
Erika Morsia, Elena Torre, Francesco Martini, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1524-1524
Open Access | Times Cited: 4
Primary and secondary myelofibrosis: ophthalmological manifestations at onset and during therapy
Olga Vinogradova, L. B. Egoryan, Д. И. Шихбабаева, et al.
Oncohematology (2025) Vol. 20, Iss. 1, pp. 95-113
Open Access
DNA Methylation in Ph-Negative Myeloproliferative Neoplasms: Prognostic Role and Therapeutic Implications
Paola Barone, Adele Bottaro, Rossana Leanza, et al.
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 4, pp. 227-227
Open Access
A comparison of sequential polymerase chain reaction–based cascade testing vs next-generation sequencing in molecular profiling of myeloproliferative neoplasms: improving testing strategies in light of evolving molecular landscapes
Xiaowei Liu, Kritika Krishnamurthy, Rizwan Naeem, et al.
Laboratory Medicine (2025)
Closed Access
A Broad Overview of Signaling in Ph-Negative Classic Myeloproliferative Neoplasms
Ana Guijarro-Hernández, J.L. Vizmanos
Cancers (2021) Vol. 13, Iss. 5, pp. 984-984
Open Access | Times Cited: 24
Molecular Pathogenesis of Myeloproliferative Neoplasms: From Molecular Landscape to Therapeutic Implications
Erika Morsia, Elena Torre, Antonella Poloni, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4573-4573
Open Access | Times Cited: 17
Progression in Myeloid Neoplasms: Beyond the Myeloblast
Carlos Faria, Alexandar Tzankov
Pathobiology (2023) Vol. 91, Iss. 1, pp. 55-75
Open Access | Times Cited: 10
Clonal Hematopoiesis and Mutations of Myeloproliferative Neoplasms
Lasse Kjær
Cancers (2020) Vol. 12, Iss. 8, pp. 2100-2100
Open Access | Times Cited: 24
Roles of Calreticulin in Protein Folding, Immunity, Calcium Signaling and Cell Transformation
Arunkumar Venkatesan, Leslie S. Satin, Malini Raghavan
Progress in molecular and subcellular biology (2021), pp. 145-162
Open Access | Times Cited: 21
Post-transcriptional regulation of erythropoiesis
Yanan Li, Haihang Zhang, Bin Hu, et al.
Blood Science (2023)
Open Access | Times Cited: 8
Combination of myeloproliferative neoplasm driver gene activation with mutations of splice factor or epigenetic modifier genes increases risk of rapid blastic progression
Stephan Bartels, Julia Vogtmann, Elisa Schipper, et al.
European Journal Of Haematology (2021) Vol. 106, Iss. 4, pp. 520-528
Open Access | Times Cited: 19
Remodeling the Bone Marrow Microenvironment – A Proposal for Targeting Pro-inflammatory Contributors in MPN
Jonas S. Jutzi, Ann Mullally
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 20
The Myeloproliferative Neoplasm Landscape: A Patient’s Eye View
Cheryl Petruk, Jonathan Mathias
Advances in Therapy (2020) Vol. 37, Iss. 5, pp. 2050-2070
Open Access | Times Cited: 18
Myeloproliferative disorders and their effects on bone homeostasis: the role of megakaryocytes
Aikaterini Karagianni, Katya Ravid
Blood (2021) Vol. 139, Iss. 21, pp. 3127-3137
Open Access | Times Cited: 15
Is there a gender effect in polycythemia vera?
Francesca Palandri, Barbara Mora, Naseema Gangat, et al.
Annals of Hematology (2020) Vol. 100, Iss. 1, pp. 11-25
Open Access | Times Cited: 15
Platelet Heterogeneity in Myeloproliferative Neoplasms
Sally Thomas, Anandi Krishnan
Arteriosclerosis Thrombosis and Vascular Biology (2021) Vol. 41, Iss. 11, pp. 2661-2670
Open Access | Times Cited: 13
Novel Molecular Insights into Leukemic Evolution of Myeloproliferative Neoplasms: A Single Cell Perspective
Sebastiano Rontauroli, Chiara Carretta, Sandra Parenti, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 15256-15256
Open Access | Times Cited: 8
Gene expression profile correlates with molecular and clinical features in patients with myelofibrosis
Sebastiano Rontauroli, Sara Castellano, Paola Guglielmelli, et al.
Blood Advances (2021) Vol. 5, Iss. 5, pp. 1452-1462
Open Access | Times Cited: 11
Enkurin: a novel marker for myeloproliferative neoplasms from platelet, megakaryocyte, and whole blood specimens
Mosale Seetharam Sumanth, Yi Liu, Jason Wu, et al.
Blood Advances (2023) Vol. 7, Iss. 18, pp. 5433-5445
Open Access | Times Cited: 4
Exploring the Molecular Landscape of Myelofibrosis, with a Focus on Ras and Mitogen-Activated Protein (MAP) Kinase Signaling
Samuel B Reynolds, Kristen Pettit, Malathi Kandarpa, et al.
Cancers (2023) Vol. 15, Iss. 18, pp. 4654-4654
Open Access | Times Cited: 4
Molecular markers as possible efficacy predictors of targeted therapy for myelofibrosis: single-center study
Olga Vinogradova, Д. И. Шихбабаева, Y. Kobzev, et al.
Oncohematology (2023) Vol. 18, Iss. 4, pp. 115-134
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top